Cite
The impact of gut microbiome-targeted therapy on liver enzymes in patients with nonalcoholic fatty liver disease: an umbrella meta-analysis.
MLA
Amini-Salehi, Ehsan, et al. “The Impact of Gut Microbiome-Targeted Therapy on Liver Enzymes in Patients with Nonalcoholic Fatty Liver Disease: An Umbrella Meta-Analysis.” Nutrition Reviews, vol. 82, no. 6, June 2024, pp. 815–30. EBSCOhost, https://doi.org/10.1093/nutrit/nuad086.
APA
Amini-Salehi, E., Hassanipour, S., Keivanlou, M.-H., Shahdkar, M., Goorabzarmakhi, M. O., Vakilpour, A., Joukar, F., Hashemi, M., Sattari, N., Javid, M., & Mansour-Ghanaei, F. (2024). The impact of gut microbiome-targeted therapy on liver enzymes in patients with nonalcoholic fatty liver disease: an umbrella meta-analysis. Nutrition Reviews, 82(6), 815–830. https://doi.org/10.1093/nutrit/nuad086
Chicago
Amini-Salehi, Ehsan, Soheil Hassanipour, Mohammad-Hossein Keivanlou, Milad Shahdkar, Mahdi Orang Goorabzarmakhi, Azin Vakilpour, Farahnaz Joukar, et al. 2024. “The Impact of Gut Microbiome-Targeted Therapy on Liver Enzymes in Patients with Nonalcoholic Fatty Liver Disease: An Umbrella Meta-Analysis.” Nutrition Reviews 82 (6): 815–30. doi:10.1093/nutrit/nuad086.